Long-Term Use of Low-Molecular-Weight Heparin in Hemodialysis Patients: A 7-Year Experience

Publisher： Karger

E-ISSN： 1421-9735|27|3|242-245

ISSN： 0253-5068

Source： Blood Purification, Vol.27, Iss.3, 2009-02, pp. : 242-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anaphylactoid Reaction Induced by Low-Molecular-Weight Heparin in a Hemodialysis Patient

By  

Nephron, Vol. 87, Iss. 1, 2001-01 ,pp. : 93-94

Karger

Access to resources Recommend Favorite

Low Molecular Weight Heparin in Hemodialysis Patients with a Bleeding Tendency

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 499-501

Karger

Access to resources Recommend Favorite

Effects of Conventional Heparin and Low-Molecular-Weight Heparin Treatment on Lipid Metabolism during a Single Hemodialysis Session

By  

Nephron, Vol. 82, Iss. 3, 1999-06 ,pp. : 286-288

Karger

Access to resources Recommend Favorite

Standard Heparin versus Low-Molecular-Weight Heparin

By  

Nephron, Vol. 92, Iss. 3, 2002-09 ,pp. : 589-600

Karger

Access to resources Recommend Favorite

Low Molecular Weight Heparin Reduces Triglyceride, VLDL and Cholesterol/HDL Levels in Hyperlipidemic Diabetic Patients on Hemodialysis

By  

American Journal of Nephrology, Vol. 18, Iss. 5, 1998-09 ,pp. : 384-390

Karger

Access to resources Recommend Favorite